Since Ki-67 is used as a cellular marker for proliferation and CD31 index is considered as a biomarker for microvessel density, we carried out immunohistochemical analysis to evaluate whether garcinol and cisplatin treatment can modulate the expression of these biomarkers to manifest their effects against HNSCC. Here, MKI67 is linked to head and neck squamous cell carcinoma.